Triple negative breast cancer (TNBC) is a molecular subtype of breast cancer and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [3]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.